Filitra (vardenafil)

Filitra is a Fortune Healthcare vardenafil family. The company evidence identifies a Professional sublingual presentation at 20 mg, while the ordinary tablet entry does not publish a complete strength range. That missing information is preserved rather than inferred from another brand’s catalogue.

“Sublingual” needs its own evidence

Vardenafil offers a concrete example of why formulation claims matter. The reference Levitra orodispersible tablet delivers different exposure from its same-number film-coated tablet and has separate instructions. Those findings concern a specific reference formulation, not Filitra Professional.

A sublingual description therefore cannot establish equivalence, faster onset or a safer interaction profile by itself. The exact product information and comparative formulation evidence would be needed before making those claims.

Compare the product, then the ingredient

The vardenafil article explains the relevant formulation studies, food context and QT precautions. Levitra supplies the reference product record; Vilitra is a different company family.

For Filitra, the practical identity questions are whether the supplied pack is an ordinary tablet or Professional presentation, what exact amount it contains, and what local leaflet applies. A named Fortune association supports the family identity, while a company sales page does not settle every clinical or authorization question. The 20 mg Professional listing should not become an instruction to substitute it for any other vardenafil form.

Filitra presentations

Each row is a presentation named by the company or by pharmacy listings.

Name	Form	Strength
Filitra	Tablet	Vardenafil (strengths not published by the company)
Filitra Professional	Sublingual tablet	Vardenafil 20 mg

Product record

Company

Fortune Healthcare Product Pvt Ltd

Strengths listed

Vardenafil 20 mg (Professional sublingual tablet)

Treatment area

Erectile dysfunction (ED)

Where we found it

In October 2026 we found it in Fortune Healthcare’s own product site, not in the Indian retail pharmacy databases we checked. Absence from the retail databases checked does not establish export-only status or current availability.

Record reviewed

4 October 2026; source retrieval dates are retained with the evidence

Listed strengths identify a product; they are not dosing advice. A listing in one country does not show that a product is authorized where you live.

About vardenafil

Vardenafil film-coated and orodispersible reference tablets are not bioequivalent. A dissolving form does not establish that every jelly or Professional product works faster. QT-related history and interacting medicines need review.

• Vardenafil: uses, safety and products

About Indian brands

Indian-company brands have different retail and catalogue evidence. A pharmacy database entry does not establish current stock, and absence from a checked database does not prove export-only manufacture. Company association, exact product identity and local authorization are separate questions.

• All Indian brands
• Checking a medicine and its source

Using a PDE5 inhibitor safely

Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.

Common side effects include headache, flushing, indigestion and a blocked nose.

• Interactions and urgent symptoms

Sources

2 sources

Checked October 4, 2026.

1. Fortune Health Care — Fortune Healthcare (company site)
2. Vardenafil hydrochloride tablets: US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.